The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022

Detalles Bibliográficos
Autores principales: Wallace, Megan, Moulia, Danielle, Blain, Amy E., Ricketts, Erin K., Minhaj, Faisal S., Link-Gelles, Ruth, Curran, Kathryn G., Hadler, Stephen C., Asif, Amimah, Godfrey, Monica, Hall, Elisha, Fiore, Anthony, Meyer, Sarah, Su, John R., Weintraub, Eric, Oster, Matthew E., Shimabukuro, Tom T., Campos-Outcalt, Doug, Morgan, Rebecca L., Bell, Beth P., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., Oliver, Sara E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942305/
https://www.ncbi.nlm.nih.gov/pubmed/35298454
http://dx.doi.org/10.15585/mmwr.mm7111a4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942305/
https://www.ncbi.nlm.nih.gov/pubmed/35298454
http://dx.doi.org/10.15585/mmwr.mm7111a4

Ejemplares similares